Francesco De Rose

Francesco De Rose has worked in a variety of roles since 2014. Francesco began their career as an Internship at A.O.U. Citta della Salute e della Scienza di Torino in 2014. Francesco then moved to Klinikum rechts der Isar der TU M\u00fcnchen in 2015, where they worked as a Postdoctoral Researcher and a PhD Student. Most recently, in 2021, they were appointed Head of Pharmaceutical Development at NUCLIDIUM AG.

Francesco De Rose has a Doctor of Philosophy - PhD from Technical University of Munich in Experimental Medicine from 2015 to 2020, a Master's degree from Università degli Studi di Torino in Chimica Clinica Forense e dello Sport from 2012 to 2015, and a Bachelor's degree from Università della Calabria in Chimica from 2008 to 2012. In addition, they obtained Theoretical and practical qualification to the ordinance on animal protection in experiments (TierSchVersV) from TransMIT GmbH in December 2016.